-
2
-
-
14544305077
-
Combination of antiangiogenic therapy with other anticancer therapies: Results, challenges, and open questions
-
Gasparini G, Longo R, Fanelli M, Teicher BA. Combination of antiangiogenic therapy with other anticancer therapies: results, challenges, and open questions. J Clin Oncol 2005; 23: 1295-1311
-
(2005)
J Clin Oncol
, vol.23
, pp. 1295-1311
-
-
Gasparini, G.1
Longo, R.2
Fanelli, M.3
Teicher, B.A.4
-
3
-
-
1242340428
-
Antiangiogenic cancer therapy
-
Cao Y. Antiangiogenic cancer therapy. Semin Cancer Biol 2004; 14:139-145
-
(2004)
Semin Cancer Biol
, vol.14
, pp. 139-145
-
-
Cao, Y.1
-
4
-
-
0035173755
-
Overview of angiogenesis: Biologic implications for antiangiogenic therapy
-
Ellis LM, Liu W, Ahmad SA, Fan F, Jung YD, Shaheen RM, Reinmuth N. Overview of angiogenesis: Biologic implications for antiangiogenic therapy. Semin Oncol 2001; 28:94-104
-
(2001)
Semin Oncol
, vol.28
, pp. 94-104
-
-
Ellis, L.M.1
Liu, W.2
Ahmad, S.A.3
Fan, F.4
Jung, Y.D.5
Shaheen, R.M.6
Reinmuth, N.7
-
5
-
-
12344337202
-
Angiogenic switch in multiple myeloma
-
Giuliani N, Colla S, Rizzoli V. Angiogenic switch in multiple myeloma. Hematology 2004; 9:377-381
-
(2004)
Hematology
, vol.9
, pp. 377-381
-
-
Giuliani, N.1
Colla, S.2
Rizzoli, V.3
-
8
-
-
12244268644
-
Molecular and cellular mechanisms of neuroprotection by vascular endothelial growth factor
-
Sun FY, Guo X. Molecular and cellular mechanisms of neuroprotection by vascular endothelial growth factor. J Neurosci Res 2005; 79:180-184
-
(2005)
J Neurosci Res
, vol.79
, pp. 180-184
-
-
Sun, F.Y.1
Guo, X.2
-
9
-
-
20344367537
-
Tumour vascular targeting
-
Neri D, Bicknell R. Tumour vascular targeting. Nat Rev Cancer 2005; 5: 436-446
-
(2005)
Nat Rev Cancer
, vol.5
, pp. 436-446
-
-
Neri, D.1
Bicknell, R.2
-
10
-
-
16844366948
-
Vascular endothelial growth factor: A therapeutic target for tumors of the Ewing's sarcoma family
-
Dalal S, Berry AM, Cullinane CJ, Mangham DC, Grimer R, Lewis IJ, Johnston C, Laurence V, Burchill SA. Vascular endothelial growth factor: a therapeutic target for tumors of the Ewing's sarcoma family. Clin Cancer Res 2005; 11: 2364-2378
-
(2005)
Clin Cancer Res
, vol.11
, pp. 2364-2378
-
-
Dalal, S.1
Berry, A.M.2
Cullinane, C.J.3
Mangham, D.C.4
Grimer, R.5
Lewis, I.J.6
Johnston, C.7
Laurence, V.8
Burchill, S.A.9
-
11
-
-
5544275438
-
Complexity in the vascular permeability factor/vascular endothelial growth factor (VPF/VEGF)-receptors signaling
-
Mukhopadhyay D, Zeng H, Bhattacharya R. Complexity in the vascular permeability factor/vascular endothelial growth factor (VPF/ VEGF)-receptors signaling. Mol Cell Biochem 2004; 264:51-61
-
(2004)
Mol Cell Biochem
, vol.264
, pp. 51-61
-
-
Mukhopadhyay, D.1
Zeng, H.2
Bhattacharya, R.3
-
12
-
-
21744434375
-
Thrombospondin-1 up-regulates expression of cell adhesion molecules and promotes monocyte binding to endothelium
-
Narizhneva NV, Razorenova OV, Podrez EA, Chen J, Chandrasekharan UM, DiCorleto PE, Plow EF, Topol EJ, Byzova TV. Thrombospondin-1 up-regulates expression of cell adhesion molecules and promotes monocyte binding to endothelium. FASEB J 2005; 19:1158-1160
-
(2005)
FASEB J
, vol.19
, pp. 1158-1160
-
-
Narizhneva, N.V.1
Razorenova, O.V.2
Podrez, E.A.3
Chen, J.4
Chandrasekharan, U.M.5
DiCorleto, P.E.6
Plow, E.F.7
Topol, E.J.8
Byzova, T.V.9
-
13
-
-
15944400631
-
Hematopoietic cells regulate the angiogenic switch during tumorigenesis
-
Okamoto R, Ueno M, Yamada Y, Takahashi N, Sano H, Suda T, Takakura N. Hematopoietic cells regulate the angiogenic switch during tumorigenesis. Blood 2005; 105: 2757-2763
-
(2005)
Blood
, vol.105
, pp. 2757-2763
-
-
Okamoto, R.1
Ueno, M.2
Yamada, Y.3
Takahashi, N.4
Sano, H.5
Suda, T.6
Takakura, N.7
-
14
-
-
0036554710
-
Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis
-
Izawa JI, Sweeney P, Perrotte P, Kedar D, Dong Z, Slaton JW, Karashima T, Inoue K, Benedict WF, Dinney CP. Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis. Clin Cancer Res 2002; 8: 1258-1270
-
(2002)
Clin Cancer Res
, vol.8
, pp. 1258-1270
-
-
Izawa, J.I.1
Sweeney, P.2
Perrotte, P.3
Kedar, D.4
Dong, Z.5
Slaton, J.W.6
Karashima, T.7
Inoue, K.8
Benedict, W.F.9
Dinney, C.P.10
-
15
-
-
10344220521
-
Endogenous angiogenesis inhibitors
-
Folkman J. Endogenous angiogenesis inhibitors. APMIS 2004; 112: 496-507
-
(2004)
APMIS
, vol.112
, pp. 496-507
-
-
Folkman, J.1
-
16
-
-
0034648765
-
Angiogenesis in cancer and other diseases
-
Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000; 407: 249-257
-
(2000)
Nature
, vol.407
, pp. 249-257
-
-
Carmeliet, P.1
Jain, R.K.2
-
17
-
-
16844384895
-
Structure and function of the plasminogen/plasmin system
-
Castellino FJ, Ploplis VA. Structure and function of the plasminogen/ plasmin system. Thromb Haemost 2005; 93: 647-654
-
(2005)
Thromb Haemost
, vol.93
, pp. 647-654
-
-
Castellino, F.J.1
Ploplis, V.A.2
-
18
-
-
12344337202
-
Angiogenic switch in multiple myeloma
-
Giuliani N, Colla S, Rizzoli V. Angiogenic switch in multiple myeloma. Hematology 2004; 9:377-381
-
(2004)
Hematology
, vol.9
, pp. 377-381
-
-
Giuliani, N.1
Colla, S.2
Rizzoli, V.3
-
19
-
-
15344340324
-
Bevacizumab: Atiangiogenic cancer therapy
-
Culy C. Bevacizumab: antiangiogenic cancer therapy. Drugs Today (Barc) 2005; 41: 23-36
-
(2005)
Drugs Today (Barc)
, vol.41
, pp. 23-36
-
-
Culy, C.1
-
20
-
-
4444271632
-
What the structure of angiostatin may tell us about its mechanism of action
-
Geiger JH, Cnudde SE. What the structure of angiostatin may tell us about its mechanism of action. J Thromb Haemost 2004; 2: 23-34
-
(2004)
J Thromb Haemost
, vol.2
, pp. 23-34
-
-
Geiger, J.H.1
Cnudde, S.E.2
-
21
-
-
0037195506
-
Angiogenesis in prostate cancer: Its role in disease progression and possible therapeutic approaches
-
van Moorselaar RJ, Voest EE. Angiogenesis in prostate cancer: its role in disease progression and possible therapeutic approaches. Mol Cell Endocrinol 2002; 197: 239-250
-
(2002)
Mol Cell Endocrinol
, vol.197
, pp. 239-250
-
-
van Moorselaar, R.J.1
Voest, E.E.2
-
22
-
-
0038711442
-
The voltage-dependent anion channel is a receptor for plasminogen kringle 5 on human endothelial cells
-
Gonzalez-Gronow M, Kalfa T, Johnson CE, Gawdi G, Pizzo SV. The voltage-dependent anion channel is a receptor for plasminogen kringle 5 on human endothelial cells. J Biol Chem 2003; 278: 27312-27318
-
(2003)
J Biol Chem
, vol.278
, pp. 27312-27318
-
-
Gonzalez-Gronow, M.1
Kalfa, T.2
Johnson, C.E.3
Gawdi, G.4
Pizzo, S.V.5
-
23
-
-
0344011492
-
Possible role of cell surface H+ -ATP synthase in the extracellular ATP synthesis and proliferation of human umbilical vein endothelial cells
-
Arakaki N, Nagao T, Niki R, Toyofuku A, Tanaka H, Kuramoto Y, Emoto Y, Shibata H, Magota K, Higuti T. Possible role of cell surface H+ -ATP synthase in the extracellular ATP synthesis and proliferation of human umbilical vein endothelial cells. Mol Cancer Res 2003; 1: 931-939
-
(2003)
Mol Cancer Res
, vol.1
, pp. 931-939
-
-
Arakaki, N.1
Nagao, T.2
Niki, R.3
Toyofuku, A.4
Tanaka, H.5
Kuramoto, Y.6
Emoto, Y.7
Shibata, H.8
Magota, K.9
Higuti, T.10
-
24
-
-
0035911953
-
Angiomotin: An angiostatin binding protein that regulates endothelial cell migration and tube formation
-
Troyanovsky B, Levchenko T, Mansson G, Matvijenko O, Holmgren L. Angiomotin: an angiostatin binding protein that regulates endothelial cell migration and tube formation. J Cell Biol 2001; 152: 1247-1254
-
(2001)
J Cell Biol
, vol.152
, pp. 1247-1254
-
-
Troyanovsky, B.1
Levchenko, T.2
Mansson, G.3
Matvijenko, O.4
Holmgren, L.5
-
25
-
-
0035955645
-
Specific interaction of angiostatin with integrin alpha(v)beta(3) in endothelial cells
-
Tarui T, Miles LA, Takada Y. Specific interaction of angiostatin with integrin alpha(v)beta(3) in endothelial cells. J Biol Chem 2001; 276: 39562-39568
-
(2001)
J Biol Chem
, vol.276
, pp. 39562-39568
-
-
Tarui, T.1
Miles, L.A.2
Takada, Y.3
-
26
-
-
1342344900
-
Aspects of human fetoplacental vasculogenesis and angiogenesis III. Changes in complicated pregnancies
-
Mayhew TM, Charnock-Jones DS, Kaufmann P. Aspects of human fetoplacental vasculogenesis and angiogenesis. III. Changes in complicated pregnancies. Placenta 2004; 25:127-139
-
(2004)
Placenta
, vol.25
, pp. 127-139
-
-
Mayhew, T.M.1
Charnock-Jones, D.S.2
Kaufmann, P.3
-
27
-
-
0036479735
-
Annexin II: A plasminogen-plasminogen activator co-receptor
-
Kim J, Hajjar KA. Annexin II: a plasminogen-plasminogen activator co-receptor. Front Biosci 2002; 7: d341-348
-
(2002)
Front Biosci
, vol.7
-
-
Kim, J.1
Hajjar, K.A.2
-
29
-
-
0141433166
-
Angiogenesis and cancer: Recent advances
-
Caceres W, Gonzalez S. Angiogenesis and cancer: recent advances. P R Health Sci J 2003; 22: 149-151
-
(2003)
P R Health Sci J
, vol.22
, pp. 149-151
-
-
Caceres, W.1
Gonzalez, S.2
-
30
-
-
0038580344
-
Long-term expression of angiostatin suppresses metastatic liver cancer in mice
-
Xu R, Sun X, Tse LY, Li H, Chan PC, Xu S, Xiao W, Kung HF, Krissansen GW, Fan ST. Long-term expression of angiostatin suppresses metastatic liver cancer in mice. Hepatology 2003; 37: 1451-1460
-
(2003)
Hepatology
, vol.37
, pp. 1451-1460
-
-
Xu, R.1
Sun, X.2
Tse, L.Y.3
Li, H.4
Chan, P.C.5
Xu, S.6
Xiao, W.7
Kung, H.F.8
Krissansen, G.W.9
Fan, S.T.10
|